1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
CA 2374775 A1 · Owner: Ortho-Mcneil Pharmaceutical, Inc. · Inventors: Scott, Malcolm K.; Wang, Hoau-Yan; Reitz, Allen B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention is directed to 1,4-dithiin- and 1,4-dithiepin- 1,1,4,4-tetroxide derivatives useful as galanin receptor antagonists for treating disorders of the central nervous system. Pharmaceutical compositions comprising the compounds of the present invention and methods of treating conditions such as an eating disorder, obesity, bulimia nervosa anorexia nervosa, binge eating, diabetes dyslipidemia, hypertension, memory loss sleep disturbances, pain, depression, anxiety Alzheimer's disease, senile dementia, cerebral hemorrhage, or diarrhea are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 2, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 2, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 2, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.